Profile
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Former positions of Mark-Andre Freyberg
| Companies | Position | End |
|---|---|---|
| BIOXXMED AG | Chief Executive Officer | 2021-09-29 |
TemplaTech GmbH
 TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | President | 2007-09-02 |
| Dermatools Biotech GmbH | Founder | - |
| Cytopharma GmbH | Founder | - |
| Technische Universität Darmstadt | Corporate Officer/Principal | - |
Training of Mark-Andre Freyberg
| Technische Universität Darmstadt | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOXXMED AG | Health Technology |
| Private companies | 3 |
|---|---|
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | Health Technology |
| Dermatools Biotech GmbH | |
| Cytopharma GmbH |
- Stock Market
- Insiders
- Mark-Andre Freyberg
